BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33220611)

  • 1. Is pneumonectomy justifiable for patients with a locoregional recurrence or persistent disease after curative intent chemoradiotherapy for locally advanced non-small cell lung cancer?
    Joosten PJM; Dickhoff C; van der Noort V; Klomp HM; van Diessen JNA; Dahele M; Bahce I; Veenhof AAFA; Smit EF; Hartemink KJ
    Lung Cancer; 2020 Dec; 150():209-215. PubMed ID: 33220611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer.
    Dickhoff C; Dahele M; Paul MA; van de Ven PM; de Langen AJ; Senan S; Smit EF; Hartemink KJ
    Lung Cancer; 2016 Apr; 94():108-13. PubMed ID: 26973215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
    Shimada Y; Suzuki K; Okada M; Nakayama H; Ito H; Mitsudomi T; Saji H; Takamochi K; Kudo Y; Hattori A; Mimae T; Aokage K; Nishii T; Tsuboi M; Ikeda N
    Interact Cardiovasc Thorac Surg; 2016 Dec; 23(6):895-901. PubMed ID: 27543652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eight cases of salvage pulmonary resection for residual disease or isolated local recurrence detected after definitive chemoradiotherapy for N2 Stage-IIIA lung cancer.
    Sawada S; Suehisa H; Ueno T; Yamashita M
    Asian J Surg; 2017 Apr; 40(2):95-99. PubMed ID: 26362070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage Lung Resections After Definitive Chemoradiotherapy: A Safe and Effective Oncologic Option.
    Bograd AJ; Mann C; Gorden JA; Gilbert CR; Farivar AS; Aye RW; Louie BE; Vallières E
    Ann Thorac Surg; 2020 Oct; 110(4):1123-1130. PubMed ID: 32473131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer.
    Dickhoff C; Unal S; Heineman DJ; Winkelman JA; Braun J; Bahce I; van Dorp M; Senan S; Dahele M
    Lung Cancer; 2023 Aug; 182():107294. PubMed ID: 37442060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
    Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
    J Cardiothorac Surg; 2016 Jan; 11():9. PubMed ID: 26781697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
    Yamaguchi M; Shimamatsu S; Edagawa M; Hirai F; Toyozawa R; Nosaki K; Seto T; Takenoyama M; Ichinose Y
    Surg Today; 2019 Mar; 49(3):197-205. PubMed ID: 30610361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage Surgery After Definitive Chemoradiotherapy for Non-small Cell Lung Cancer.
    Casiraghi M; Maisonneuve P; Piperno G; Bellini R; Brambilla D; Petrella F; Marinis F; Spaggiari L
    Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):233-241. PubMed ID: 28823336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease.
    Kim HK; Cho JH; Choi YS; Zo JI; Shim YM; Park K; Ahn MJ; Ahn YC; Kim K; Kim J
    Lung Cancer; 2016 Jun; 96():56-62. PubMed ID: 27133751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage chemoradiotherapy with cisplatin and vinorelbine for postoperative locoregional recurrence of non-small cell lung cancer.
    Hisakane K; Yoh K; Nakamura N; Udagawa H; Kirita K; Umemura S; Matsumoto S; Niho S; Akimoto T; Tsuboi M; Goto K
    Medicine (Baltimore); 2017 Nov; 96(47):e8635. PubMed ID: 29381935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchoplastic Procedure Versus Pneumonectomy After High-dose Radiation for Non-small Cell Lung Cancer.
    Watanabe Y; Suzuki K; Hattori A; Fukui M; Matsunaga T; Oh S; Takamochi K
    Ann Thorac Surg; 2021 Dec; 112(6):1832-1840. PubMed ID: 33359721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage surgery in lung cancer following definitive therapies.
    Eisenberg M; Deboever N; Antonoff MB
    J Surg Oncol; 2023 Feb; 127(2):319-328. PubMed ID: 36630094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
    Rajaram R; Correa AM; Xu T; Nguyen QN; Antonoff MB; Rice D; Mehran R; Roth J; Walsh G; Swisher S; Hofstetter WL; Vaporciyan A; Cascone T; Tsao AS; Papadimitrakopoulou VA; Gandhi S; Liao Z; Sepesi B
    Clin Lung Cancer; 2020 Jul; 21(4):e294-e301. PubMed ID: 32089476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimodality vs Chemoradiation and Salvage Resection in cN2 Stage IIIA Non-Small Cell Lung Cancer.
    Ye JC; Ding L; Atay SM; Nieva JJ; McFadden PM; Chang E; Kim AW
    Semin Thorac Cardiovasc Surg; 2020; 32(1):153-159. PubMed ID: 31220530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Survival after Salvage Surgery for Local Failure after Definitive Chemoradiation Therapy for Locally Advanced Non-small Cell Lung Cancer.
    Schreiner W; Dudek W; Lettmaier S; Fietkau R; Sirbu H
    Thorac Cardiovasc Surg; 2018 Mar; 66(2):135-141. PubMed ID: 28992654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neo-adjuvant Chemo-Radiation to 60 Gray Followed by Surgery for Locally Advanced Non-Small Cell Lung Cancer Patients: Evaluation of Trimodality Strategy.
    Appel S; Goldstein J; Perelman M; Rabin T; Urban D; Onn A; Shulimzon TR; Weiss I; Lieberman S; Marom EM; Golan N; Simansky D; Ben-Nun A; Lawrence YR; Bar J; Symon Z
    Isr Med Assoc J; 2017 Oct; 19(10):614-619. PubMed ID: 29103238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage surgery after definitive chemo-radiotherapy for patients with Non-Small Cell Lung Cancer.
    Romero-Vielva L; Viteri S; Moya-Horno I; Toscas JI; Maestre-Alcácer JA; Ramón Y Cajal S; Rosell R
    Lung Cancer; 2019 Jul; 133():117-122. PubMed ID: 31200817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage surgery after definitive chemoradiotherapy for patients with non-small cell lung cancer.
    Hamada A; Soh J; Mitsudomi T
    Transl Lung Cancer Res; 2021 Jan; 10(1):555-562. PubMed ID: 33569336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is salvage surgery for recurrent non-small-cell lung cancer after definitive non-operative therapy associated with reasonable survival?
    Schreiner W; Dudek W; Sirbu H
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):682-4. PubMed ID: 26323288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.